PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 3 filers reported holding PRECIGEN INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59 | +25.5% | 41,576 | +1.2% | 0.00% | – |
| Q2 2023 | $47 | -4.1% | 41,076 | -10.3% | 0.00% | – |
| Q1 2023 | $49 | -42.4% | 45,813 | -17.7% | 0.00% | – |
| Q4 2022 | $85 | -99.9% | 55,676 | -0.3% | 0.00% | -100.0% |
| Q3 2022 | $118,000 | +51.3% | 55,826 | +3.1% | 0.00% | – |
| Q2 2022 | $78,000 | -33.9% | 54,151 | -2.8% | 0.00% | -100.0% |
| Q1 2022 | $118,000 | -45.4% | 55,726 | -4.4% | 0.00% | 0.0% |
| Q4 2021 | $216,000 | -24.2% | 58,268 | +2.1% | 0.00% | 0.0% |
| Q3 2021 | $285,000 | -14.4% | 57,093 | +11.6% | 0.00% | 0.0% |
| Q2 2021 | $333,000 | +37.0% | 51,143 | +45.1% | 0.00% | 0.0% |
| Q1 2021 | $243,000 | -31.9% | 35,243 | +0.8% | 0.00% | -50.0% |
| Q4 2020 | $357,000 | +156.8% | 34,968 | -12.1% | 0.00% | +100.0% |
| Q3 2020 | $139,000 | -29.4% | 39,768 | +0.5% | 0.00% | 0.0% |
| Q2 2020 | $197,000 | +42.8% | 39,563 | -2.3% | 0.00% | 0.0% |
| Q1 2020 | $138,000 | – | 40,513 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |